Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature
The therapeutic modalities of early-stage and advanced extranodal natural killer/T-cell lymphoma (NKTCL) patients are completely different. The former is mainly radiotherapy with or without chemotherapy, while the latter relies on chemotherapy-based systemic treatment.1,2 According to Ann Arbor sta...
Main Authors: | Zhe-Sheng Chen, Dong-Hua Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021-08-01
|
Series: | Bosnian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/6419 |
Similar Items
-
Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis
by: Jayati Mallick, et al.
Published: (2020-09-01) -
Extranodal natural killer/T‐cell lymphoma in an 11‐year‐old child
by: Takeshi Ninchoji, et al.
Published: (2020-12-01) -
Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases
by: Fadi Al Akhrass, et al.
Published: (2016-01-01) -
Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma
by: Lin-Shu Zeng, et al.
Published: (2017-12-01) -
Skin lesion of extranodal natural killer/T‐cell lymphoma nasal type
by: Koichiro Okumura, et al.
Published: (2021-09-01)